Skip to content
HW190814 Banners for ADC SD v22

Maximizing the Clinical Therapeutic Index of Antibody-drug Conjugates

 

Celebrating its 10th year, World ADC San Diego continues to be the industry-leading conference to help forward thinking researchers from the pharmaceutical, biotech and academic community advance the development of antibody-drug conjugates.

This year, you’ll hear from 88+ industry expert speakers. They will give detailed presentations over 4 streams, 3 focused seminar days and 9 interactive workshops addressing challenges including;

  • The practical conundrums of operating an ADC clinical trial to improve biomarker and patient selection strategies
  • Understanding the relationship between payload, linker and antibody to clinically increase efficacy
  • Aligning the complex ADC supply networks for making drug product for patients to ensure an efficient Supply Chain Process
  • Using DMPK modelling to mitigate toxicities and allow for smoother translation into the clinic

Take advantage of this unrivalled learning and networking opportunity across four days. World ADC San Diego is packed with content and dedicated interactive formats, making sure that you leave equipped with the connections and takeaways you need to maximize the clinical therapeutic window of your ADC candidate.

Don’t miss this opportunity to join your fellow scientists at the heart of the ADC community. Join 600+ of your peers, from 230 organizations for your most valuable ADC event of 2019.

Snapshot of Our World-Class Speaker Faculty

Amy Han

Director of Research & Development

Regeneron Pharmaceuticals

Andrew Phillips

Director, Next Generation Antibody Drug Conjugates

AbbVie

Bill Boyle

Chief Science Officer & Vice President - Translational Medicine

BioAtla

Chunyan Song

Senior Medical Director

Genentech

John Lambert - ImmunoGen

John Lambert

Executive Vice President, Emeritus & Distinguished Fellow

ImmuonoGen

Chris Leamon

Vice President of Discovery Research

Endocyte

Firelli Alonso

Senior Director, External Supply

Pfizer

Greg Thurber

Associate Professor

University of Michigan

Jay Harper

Associate Director

AstraZeneca

Tim Lowinger - Mersana

Tim Lowinger

Chief Scientific Officer

Mersana

Video Highlights

"The conference is an awesome opportunity to learn what has been happening and also what to expect in the future, from both technology and business perspective"

MilliporeSigma

“This conference is the pre-eminent ADC conference where the top companies come to present their data and share their experiences”

Ambrx

“Very informative, focused conference on all aspects of ADC research and development”

Bayer

About World ADC Series

The World ADC team ploughs its collective energy into sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distill this into accessible formats of information exchange – for you. From globally leading conferences, to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.

The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavors more informed and more robust.

We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.

Join us at the heart of the ADC community to improve your programs and be part of the mission to develop better antibody drug conjugate drugs.

Other Events In The Series

Proud To Partner With

Lead Partner:

Senior Partners: